Sallie Schneider to Antineoplastic Agents
This is a "connection" page, showing publications Sallie Schneider has written about Antineoplastic Agents.
Connection Strength
0.608
-
Dudek MC, Wong KE, Bassa LM, Mora MC, Ser-Dolansky J, Henneberry JM, Crisi GM, Arenas RB, Schneider SS. Antineoplastic effects of Rhodiola crenulata treatment on B16-F10 melanoma. Tumour Biol. 2015 Dec; 36(12):9795-805.
Score: 0.337
-
Wong KE, Mora MC, Sultana N, Moriarty KP, Arenas RB, Yadava N, Schneider SS, Tirabassi MV. Evaluation of Rhodiola crenulata on growth and metabolism of NB-1691, an MYCN-amplified neuroblastoma cell line. Tumour Biol. 2018 Jun; 40(6):1010428318779515.
Score: 0.103
-
McRae Page S, Henchey E, Chen X, Schneider S, Emrick T. Efficacy of polyMPC-DOX prodrugs in 4T1 tumor-bearing mice. Mol Pharm. 2014 May 05; 11(5):1715-20.
Score: 0.077
-
Chen X, Parelkar SS, Henchey E, Schneider S, Emrick T. PolyMPC-doxorubicin prodrugs. Bioconjug Chem. 2012 Sep 19; 23(9):1753-63.
Score: 0.069
-
Wong KE, Mora MC, Skinner M, McRae Page S, Crisi GM, Arenas RB, Schneider SS, Emrick T. Evaluation of PolyMPC-Dox Prodrugs in a Human Ovarian Tumor Model. Mol Pharm. 2016 05 02; 13(5):1679-87.
Score: 0.022